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Mycobacterium tuberculosis is a gram positive 
acid fast, slender-straight rod that is 
ubiquitous.[1] It is a strict aerobe and thrives best 
in organs with relatively high oxygen tension and 
thus thrives easily in the apices of the lungs.[1]  
The organism is transmitted exclusively by 
inhalation of infective droplets from patients with 
open pulmonary tuberculosis via coughing, 
sneezing, talking or expectorating.[1] The 
pathogen is found in human samples and also in 
water and soil. It is hardy and known to survive 
outside the human host for decades.[1] 
 
Tuberculosis has been identified as the leading 
cause of death from any single pathogen and it 
has consistently continued to be a major public 
health challenge globally. Data available show 
that Nigeria ranks tenth among the 22 high 
tuberculosis burden countries with up to 98000 
patients notified in 2012 accounting for an 
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estimated prevalence rate of 161 per 100,000 
population thereby ascribing the country the 
status of a high disease burden nation.[2] 
 
It has also been estimated by epidemiologists 
that about one-third of the world’s population are 
currently infected or have been exposed to 
Mycobacterium tuberculosis, particularly those in 
Sub Saharan Africa and Asia and that about 
three million deaths are attributable to 
tuberculosis each year despite the availability of 
antibiotics that are potentially curative for this 
chronic infectious disease.[3] 
 
A risk factor study showed that tuberculosis is 
strongly associated with the following variable; 
male gender, a family history of tuberculosis, 
absence of a BCG scar, cigarette smoking, 
alcohol use, chronic anaemia, HIV co-infection, 
and previous history and treatment of helminthic 
infections. In a multivariable model in that study 
that was based on 601 matched pairs of 
subjects, male sex, family history of 
tuberculosis, smoking, and HIV infection were 
independent risk factors of tuberculosis.[4] 
 
Tuberculosis can affect any organ system.[5] 
Clinical manifestations vary accordingly but 
often include fever, night sweats, and weight 
loss.[5] Positive results on either a tuberculin skin 
test or an interferon-γ release assay in the 
absence of active TB establish a diagnosis of 
LTBI.[5] A combination of epidemiological, 
clinical, radiographic, microbiological, and 
histopathologic features is used to establish the 
diagnosis of active TB.[5] 
 
The burden of tuberculosis in our local 
environment appears to be on the high side. At 
the moment Babcock University Teaching 
Hospital, being a fledgling medical institution, 
lacks baseline data on the profile of tuberculosis. 
The study thus sought to describe the burden of 
tuberculosis in Babcock University Teaching 
Hospital in order to better understand the 
presentation patterns for improved diagnosis. It 
also seeks to describe the epidemiologic profiles 
of tuberculosis infections at our local institution 
since no such previous study had been done in 
our institution. 
 
This study will avail us the opportunity of 
knowing the true picture of the burden of 
disease in order for us to formulate rational 
measures in line with national programs towards  
addressing the problem. In addition, BUTH 
serves as a referral facility for at least three 
Primary Health Centers within its vicinity, thus 
this study will help to provide information on the 
picture within our local environment. The data 
obtained from this study will therefore act as 
baseline information for future studies to be 
conducted on tuberculosis and help us to 
conduct a trend analysis with respect to 
morbidity, drug resistance complications and 





Ilishan is located in Ogun State in South West 
Nigeria. The Babcock University Teaching 
Hospital is a 140 bed facility that caters for the 
immediate community and surrounding environs. 
It has a Directly Observed Treatment Short 
Course (DOTS) clinic supported by the National 
Tuberculosis and Leprosy Control Project 
(NTBLCP).It also serves as a referral center for 
three Primary Health Care Centers (PHC’s) – 
Ikenne, Iperu and Shagamu. 
 
Study design and methods 
This is a retrospective cross sectional study. 
Only patients with clinical features of 
tuberculosis were included in the study. Sputum 
smear examination on three consecutive 
specimens had been performed with the Ziehl 
Nelson method for staining acid fast bacilli and 
these records were recovered from laboratory 
data in the Medical Microbiology Tuberculosis 
Laboratory. The Ziehl-Neelson procedure was 
used to stain Mycobacterium tuberculosis and 
Mycobacterium leprae. The study was approved 
by the institution ethical committee. 
 
A retrospective analysis of the profile and 
treatment outcomes of all tuberculosis patients 
registered from September 2013 to September 
2015 at DOTS Clinic was retrieved. Reviewed 
data were patients’ ages, genders, addresses, 
tuberculosis types, and sputum smear status as 
well as treatment outcome.  
 
Sample size 
The sample size was calculated using the Kish 
formula N = Z2pq/d2where N is the sample size, 
p is the prevalence, d = 1-p and d = 0.05. With a 
prevalence of 15% [6] this results in a sample 
size of 200 patients. 
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This included both in- and out-patients receiving 
tuberculosis diagnostic services at the 
Department of Medical Microbiology, Babcock 
University Teaching Hospital. All patients within 
the time period of November 2014 to November 
2015 were included in the study. 
 
Statistical analysis 
Data was entered and analyzed using Epi Info 




with 95% confidence intervals, and descriptive 
statistics - including mean/median shall be 
computed. The possible determinants (age, 
gender, residence, HIV status, smear status) 
shall be assessed. Significance tests are two-
sided with P-values < 0.05 considered 
statistically significant. Chi-square test was used 
to evaluate differences in categorical variables. 
The Fisher's exact test was used when cell sizes 
were < 5. 
Table 1: Frequency distribution of participants and variables 
Variable  Frequency Percentage 
Ethnicity Yoruba 145 80.1 
 Ibo 18 9.9 
 Others 11 6.1 
 Hausa 7 3.9 
Age Category < 40 113 66.5 
 > 40 57 33.5 
Gender Female 106 59.6 
 Male 72 40.4 
Sputum 1 + 7 4.0 
 ++ 6 3.4 
 +++ 10 5.6 
 0 152 85.9 
 Scanty 2 1.1 
Sputum 2 + 6 3.8 
 ++ 13 1.9 
 +++ 14 8.9 
 0 133 84.2 
 Scanty 2 1.3 
Sputum 3 + 3 4.1 
 ++ 2 2.7 
 +++ 10 13.5 
 0 59 79.7 
HIV Negative 50 27.9 
 Not available 64 35.8 
 Positive 65 36.3 
Clinical Improvement No 22 12.4 
 Yes 155 87.6 
AFB Seen No 152 84 
 Yes 29 16 
Sample type Aspirates 5 2.8 
 Sputum 176 97.2 
Treatment facility BUTH 138 76.2 
 PHC 43 23.8 
Age group Adult 152 89.4 
 Pediatric 18 10.6 
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Table 2: Risk factors for acquisition of tuberculosis and HIV 
Variable    P value Χ2 O.R R.R CI 
Treatment facility  AFB Seen 0.05 3.83 2.29 1.17 1.0 – 5.34 
  None Yes      
BUTH  120 18      
PHC  32 11      
Treatment facility  HIV       
 Negative NA Positive 0.00 24.74    
BUTH 44 35 57      
PHC 6 28 8      
Age group  HIV       
 Negative NA Positive 0.11 4.38    
Adult 45 49 56      
Pediatric 5 10 3      
Gender  HIV       
 Negative NA Positive 0.09 4.74    
Female 24 37 43      
Male 26 26 20      
Age  HIV       
 Negative NA Positive 0.83 0.38    
< 40 32 41 39      
> 40 18 18 20      
Treatment facility  Improvement 0.23 1.41 2.13 1.97 0.60– 7.59 
BUTH  None Yes      
PHC  19 116      
  3 39      
Age   Improvement 0.55 0.35 1.31 1.36 0.50-3.71 
  None  Yes      
< 40  15 94      
> 40  6 51      
Age group  Improvement 0.90 0.01 1.08 1.10 0.23-5.17 
  None Yes      
Adult  19 130      
Pediatric  2 15      
Age group  AFB Seen 0.52 0.42 0.93 0.61 0.13-2.80 
  None Yes      
Adult   126 26      
Pediatric  16 2      
 
 









     
  None Yes 0.14 2.20 0.90 0.49 0.19-1.28 
< 40  91 22      
> 40  51 6      
Gender  AFB  Seen 0.76 0.10 0.88 1.0 0.39-2.00 
  None Yes      
Female  88 18      
Male  61 11      
AFB – Acid fast bacilli, NA – Not available 
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In all, 181 patients’ records from the laboratory 
register were analyzed. The predominant ethnic 
group in the study were the Yoruba’s as they 
accounted for n = 145 (80.1%) of participants 
while the other tribes accounted for 29.1%.  
Regarding age stratification, most respondents, 
n = 113, (66.5%) were less than forty years with 
the rest older than forty years. Most participants, 
n = 106, (59.6%) were female, with males n = 72 
(40.4%) accounting for the remainder.  With 
respect to sputum analysis for Acid Fast Bacilli, 
25 out of 177 1st samples, 35 of 166 2nd 
samples and 15 of 74 3rd samples were positive 
respectively (table 1). 
 
The prevalence of HIV in the study is 36.3%. 
About 155 (86.7%) showed clinical improvement 
following two months of anti-kochs therapy. In 
addition 29 (16%) of all sputum samples were 
conclusively positive for Acid Fast bacilli by the 
Ziehl Nelson stain, as opposed to 152 (84%) 
that were negative. The predominant sample 
type for Mycobacterial analysis was sputum n = 
176 (97.2%), with aspirates making up n = 5 
(2.8%). Majority of patients received care in a 
tertiary hospital n = 138 (76.2%). Most cases 
seen were in adults n = 152 (89.4%) (table 1). 
 
Concerning tests of significant statistical 
associations, patients presenting to BUTH 2.29 
times more likely to have a positive AFB sputum 
smear result when compared to samples from 
Primary Health Care Centers; P = 0.05, χ2 = 
3.83, O.R = 2.29, R.R = 1.17, CI = 1.0 – 5.34. 
Patients presenting to BUTH were more likely to 
be HIV positive when compared to those from 
PHCs P= 0.00, χ2 = 24.74, df = 2. There was no 
statistically significant association between HIV 
status and age or gender. Also there was also 
none seen with clinical improvement and either 
age or the location of the treatment facility. 
There was also no increased likelihood of 





Tuberculosis is a global emergency that is 
responsible for approximately two million deaths 
annually and is one of the leading causes of 
death among curable infectious diseases[6]. The 
tuberculosis and human immunodeficiency virus 
(HIV) epidemics are fueling each other in many 
African countries.[6] The data from our laboratory 
show a concomitant high burden of disease with 
HIV and tuberculosis similar with other series 
such as those of Beijerand his colleagues.[6] 
 
Our rate of HIV in suspected tuberculosis 
patients was 36.3% representing more than a 
third of all patients. In addition, almost a third of 
patients did not have available retroviral screen 
results and this implies a break in the diagnostic 
chain of tuberculosis management as all 
patients with the disease condition must have a 
retroviral screen. The higher association of HIV 
with patients in our tertiary hospital compared to 
those from the PHCs might be due to higher 
transmission rates in a semi-urban environment 
than in a rural one, ditto for the higher detection 
rates of AFB in sputum samples in our Tertiary 
hospital. 
 
Tuberculosis is a major opportunistic infection in 
HIV-infected persons and also represents an 
AIDS defining illness. As a result of this, the 
clinical conditions end up forming a lethal 
combination with each speeding up the other's 
progress. It is also observed that the present 
ongoing tuberculosis epidemic has been 
associated with several cases also in immune-
competent individuals.[7] 
 
The World Health Organization (WHO) 
estimates that 460,000 new cases of all forms of 
tuberculosis occurred in Nigeria in the year 2009 
giving a grim picture despite concerted efforts 
geared at bringing down new cases to an 
acceptable minimum. In addition, the burden of 
the disease is further compounded by a 
relatively high prevalence of HIV in the country 
which is approximately 4.6% in the population. 
This high prevalence of HIV among tuberculosis 
patients indicates that the tuberculosis challenge 
will continue to be fueled by HIV.[8] 
 
The findings from our study show that the 
burden of tuberculosis is still high in our 
environment and challenges in its rapid and 
accurate diagnosis still remain. The early 
diagnosis and prompt treatment remain 
essential components for effective tuberculosis 
control.[9] Any form of delay in the diagnosis of 
tuberculosis may increase infectivity to the 
immediate and remote communities, worsen the 
disease state, result in complications and 
enhance the risk of death. Delays in diagnosis 
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are usually due to late presentation on the part 
of patients, self medication, resorting to 
alternative forms of therapies as well as a low 
index of suspicion on the part of primary care 
givers.[9] 
 
Studies have revealed that early diagnosis and 
prompt and appropriate management of 
infectious patients with pulmonary and extra-
pulmonary tuberculosis help to reduce the 
transmission of Mycobacterium tuberculosis 
which would result in the elimination of the 
scourge. The higher rates of AFB detection in 
patients less than forty years show that 
understanding transmission patterns in 
individuals in this age group is key to the control 
of tuberculosis in our local environment.  If 
tuberculosis is detected early and properly 
treated using effective combination 
chemotherapy, the patients usually become 
noninfectious within the first two months and are 
eventually cured. However, important challenges 
for tuberculosis control are human 
immunodeficiency virus (HIV) co-infection and 
drug resistance which is rapidly emerging even 
in treatment naïve patients.[10] 
 
The present WHO international policy on 
tuberculosis case detection recommends the 
collection and examination of two sputum 
smears for the diagnosis of pulmonary 
tuberculosis as opposed to three previously 
used.[11] Our findings showed that most patients 
submitted two sputum samples and tuberculosis 
was reliably diagnosed with those two samples 
which is in line with studies conducted by 
Parsons et al. where almost 85.8% of 
tuberculosis cases were detected with the first 
sputum specimen.[11] With the second sputum 
specimen, the average incremental yield was 
11.9%, while the incremental yield of the third 
specimen, when the first two specimens were 
negative was 3.1% which was negligible and 
added little information to the management of 
the patient.[11] 
 
The accurate and rapid diagnosis of 
Mycobacterium tuberculosis infection and 
tuberculosis diseases is a formidable global 
challenge that is further complicated by HIV co-
infection and the emergence of Multidrug 
Resistant (MDR) and Extensively drug Resistant 
(XDR) strains.[12] Delayed or absent tuberculosis 
diagnosis results in the delay and/or absence of 
appropriate treatment, therefore increasing 
morbidity, mortality, and mycobacterial 
transmission.[12] This is best evidenced by 
several recent autopsy studies from African 
countries, including South Africa, that revealed 
that up to 50% of persons with HIV infection or 
AIDS have unsuspected tuberculosis at the time 
of death.[12] 
 
Globally, tuberculosis accounts for 1.2 – 1.5 
million deaths each year, with 85% of this 
occurring in developing countries (such as 
Nigeria) and 26% in Sub Saharan Africa. 
Tuberculosis reemerged as a major global public 
health concern around the mid 1980s shortly 
after the onset of the HIV/AIDS pandemic.[13] 
 
The other possible causes of re-emergence are 
due to rapid increase in poverty, poor living 
conditions with overcrowding, war, malnutrition, 
lack of drugs, the chronic problem of poor 
funding of local National Tuberculosis Programs, 
and non-adherence to program policies by some 
host governments.[13] These factors ultimately 
lead to increased transmission of 
Mycobacterium tuberculosis in the community 
and also to an increased risk of progression 
from latent to overt clinical tuberculosis.[13] 
 
To impact on the high rates of both prevalent 
and incident tuberculosis in this and other 
resource poor settings, and to prevent 
associated high mortality and morbidity, a 
combination of strategies must be used.[14] This 
should include preventing late entry into HIV 
care and onto antiretroviral therapy, infection 
control measures around tuberculosis, targeted 
enhanced screening and enhanced adherence 
support for those on both tuberculosis and HIV 
treatment.[14] 
 
Tuberculosis poses a severe challenge to public 
health globally but disproportionately affects 
resource constrained nations who have poorly 
developed Public Health systems. Individuals 
who have close contact with a patient who has 
active pulmonary tuberculosis and people from 
endemic regions of the world are at highest risk 
of primary infection, whereas patients with 
compromised immune systems have the highest 
risk of reactivation of latent tuberculosis infection 
from prior exposure.[15] 
 
To stop the spread of the disease, treatment of 
active pulmonary tuberculosis patients remains 
the most effective strategy since a contagious 
person will infect up to 15 people every year if 
left untreated.[16] A World Health Assembly 
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resolution invigorated the tuberculosis control 
efforts and the internationally recommended 
control therapy, later named DOTS (Directly 
Observed Therapy Short Course) was 
launched.[16] However, interruption in 
tuberculosis treatment still remains the major 
barrier to its control and is the most important 
challenge for control.[16] Such interruptions are a 
breeding ground for Multidrug Resistant 





Although not all records were useable due to 
incomplete filling of biodata on the laboratory 
request forms, and samples providing in few 
instances were not suitable for analysis such as 
saliva instead of sputum. The observations from 
the present study revealed that tuberculosis in 
the 21st century still remains a huge public 
health issue despite gains and advances in 
diagnosis and chemotherapy. In order to 
strengthen tuberculosis control programs, 
attention needs to be placed on rapid diagnosis 
in rural and semi-urban areas as this will limit 





In the light of the emerging threat of Multidrug 
Resistant Tuberculosis (MDR), which is a huge 
cause for concern, concerted effort needs to be 
put in place to halt this trend and more sensitive 
equipment such as the GeneXpert should be 
made available in remote locations to help 
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